Carol A. Mercer

6.0k citations

23 papers · 1.6k indexed · h-index 16

Molecular Biology top 10%
Epidemiology top 5%
Oncology top 10%
Immunology top 10%
Cancer Research top 10%

Co-authors: George Thomas Alagammai Kaliappan Sara C. Kozma Suresh Peddigari Giulio Donati Angela F. Drew Molly M. McFarland-Mancini Mingfu Zhou
Topics: PI3K/AKT/mTOR signaling in cancer (9 papers)Autophagy in Disease and Therapy (6 papers)RNA modifications and cancer (5 papers)
Cited by: Physiology Epidemiology Molecular Biology
Journals: Nature Communications Journal of Clinical Oncology Blood
Partner nations: United States Spain Netherlands

In The Last Decade

Carol A. Mercer

23 papers receiving 1.6k citations

Peers

Countries citing papers authored by Carol A. Mercer

Since Specialization

Citations

This map shows the geographic impact of Carol A. Mercer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Mercer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Mercer more than expected).

Fields of papers citing papers by Carol A. Mercer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Mercer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Mercer. The network helps show where Carol A. Mercer may publish in the future.

Co-authorship network of co-authors of Carol A. Mercer

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Mercer. A scholar is included among the top collaborators of Carol A. Mercer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Mercer. Carol A. Mercer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death 2021 ·Blood ·(unknown),Suresh Peddigari,Carol A. Mercer,(unknown),(unknown),(unknown),Virginia Amador,Sarah T. Diepstraten,Gemma L. Kelly,Ramón Salazar,Sara C. Kozma,Eric Kusnadi,Jian Kang,Antonio Gentilella,Richard B. Pearson,George Thomas,Joffrey Pelletier	17
2	Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTOR 2018 ·Clinical Cancer Research ·Sónia R. Veiga,Xuemei Ge,Carol A. Mercer,María Isabel Hernández‐Álvarez,Hala Elnakat Thomas,Javier Hernández‐Losa,Santiago Ramón y Cajal,António Zorzano,George Thomas,Sara C. Kozma	36
3	mTOR kinase inhibition reduces tissue factor expression and growth of pancreatic neuroendocrine tumors 2018 ·Journal of Thrombosis and Haemostasis ·(unknown),Hala Elnakat Thomas,(unknown),(unknown),(unknown),(unknown),(unknown),Yohei Hisada,H W Davis,Xiaoyang Qi,Carol A. Mercer,Fred V. Lucas,Bruce J. Aronow,Nigel Mackman,Henri H. Versteeg,Vladimir Y. Bogdanov	11
4	Hepatic Ago2-mediated RNA silencing controls energy metabolism linked to AMPK activation and obesity-associated pathophysiology 2018 ·Nature Communications ·Cai Zhang,Joonbae Seo,Kazutoshi Murakami,(unknown),(unknown),Vishnupriya J. Borra,Kwangmin Choi,Celvie L. Yuan,Calvin C. Chan,Xiaoting Chen,Taosheng Huang,Matthew T. Weirauch,Senad Divanovic,Nathan Qi,(unknown),Carol A. Mercer,Haruhiko Siomi,Takahisa Nakamura	36
5	Mitochondrial Complex I Activity Is Required for Maximal Autophagy 2018 ·Cell Reports ·Hala Elnakat Thomas,Yu Zhang,Jonathan A. Stefely,Sónia R. Veiga,George Thomas,Sara C. Kozma,Carol A. Mercer	80
6	mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment 2017 ·Molecular Cancer Therapeutics ·(unknown),Zhengtao Chu,Min Jiang,(unknown),(unknown),Sheryl E. Koch,Vinicius Carreira,(unknown),David R. Plas,Kakajan Komurov,Xiaoyang Qi,Carol A. Mercer,Lowell Anthony,Jack Rubinstein,H. Emerson Thomas	13
7	A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies 2017 ·Targeted Oncology ·Trisha M. Wise‐Draper,Ganesh Moorthy,Mohamad A. Salkeni,Nagla Abdel Karim,Hala Elnakat Thomas,Carol A. Mercer,Muhammad S. Beg,(unknown),Olugbenga Olowokure,Hassana Fathallah,Sara C. Kozma,George Thomas,Olivier Rixe,Pankaj B. Desai,John C. Morris	95
8	A Dose Escalation Single Arm Phase Ib Combination Study of BEZ235 with Everolimus in Patients with Advanced Solid Malignancies 2015 ·Annals of Oncology ·Trisha M. Wise‐Draper,Ganesh Moorthy,Mohamad A. Salkeni,Howard Thomas,Carol A. Mercer,Sara C. Kozma,George Thomas,Olivier Rixe,Pankaj B. Desai,John C. Morris,Olugbenga Olowokure	1
9	A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report 2014 ·Clinical Cancer Research ·Maryam Fouladi,John P. Perentesis,Lars M. Wagner,Alexander A. Vinks,Joel M. Reid,Charlotte H. Ahern,George Thomas,Carol A. Mercer,Darcy A. Krueger,Peter J. Houghton,L. Austin Doyle,Helen Chen,Brenda J. Weigel,Susan M. Blaney	16
10	Loss of Tumor Suppressor RPL5/RPL11 Does Not Induce Cell Cycle Arrest but Impedes Proliferation Due to Reduced Ribosome Content and Translation Capacity 2013 ·Molecular and Cellular Biology ·Teng Teng,Carol A. Mercer,(unknown),George Thomas,Stefano Fumagalli	74
11	Growth control and ribosomopathies 2013 ·Current Opinion in Genetics & Development ·Teng Teng,George Thomas,Carol A. Mercer	89
12	5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint 2013 ·Cell Reports ·Giulio Donati,Suresh Peddigari,Carol A. Mercer,George Thomas	200
13	BEZ235 in combination with everolimus for advanced solid malignancies: Preliminary results of a phase Ib dose-escalation study. 2013 ·Journal of Clinical Oncology ·Mohamad A. Salkeni,Olivier Rixe,Nagla Abdel Karim,(unknown),(unknown),Ganesh Moorthy,Carol A. Mercer,H. Emerson Thomas,Pankaj B. Desai,Hassana Fathallah,Sara C. Kozma,George Thomas,John C. Morris	6
14	mTOR Inhibitors Synergize on Regression, Reversal of Gene Expression, and Autophagy in Hepatocellular Carcinoma 2012 ·Science Translational Medicine ·Hala Elnakat Thomas,Carol A. Mercer,Larissa S. Carnevalli,Jongsun Park,Jesper B. Andersen,Elizabeth A. Conner,Kazuhiro Tanaka,Tomoo Matsutani,Akio Iwanami,Bruce J. Aronow,Manway Liu,Saveur-Michel Maira,Snorri S. Thorgeirsson,Paul S. Mischel,George Thomas,Sara C. Kozma	81
15	Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells 2011 ·Clinical & Experimental Metastasis ·Premkumar Vummidi Giridhar,(unknown),Catherine A. Gallo,Aleksey Porollo,Carol A. Mercer,David R. Plas,Angela F. Drew	12
16	Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor 2010 ·The Journal of Immunology ·Molly M. McFarland-Mancini,(unknown),Andrew M. Paluch,Mingfu Zhou,Premkumar Vummidi Giridhar,Carol A. Mercer,Sara C. Kozma,Angela F. Drew	209
17	Chapter 7 The GST‐BHMT Assay and Related Assays for Autophagy 2009 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown),Carol A. Mercer	21
18	A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy 2009 ·Autophagy ·Carol A. Mercer,Alagammai Kaliappan,(unknown)	336
19	Macroautophagy-dependent, intralysosomal cleavage of a betaine homocysteine methyltransferase fusion protein requires stable multimerization 2008 ·Autophagy ·Carol A. Mercer,Alagammai Kaliappan,Patrick B. Dennis	14
20	Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice 2007 ·Cancer Research ·Toni M. Robinson-Smith,Idit Isaacsohn,Carol A. Mercer,Mingfu Zhou,Nico van Rooijen,Nader Husseinzadeh,Molly M. McFarland-Mancini,Angela F. Drew	165

About Carol A. Mercer

Carol A. Mercer is a scholar working on Oncology, Molecular Biology and Genetics, having authored 23 papers that have together received 1.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Autophagy in Disease and Therapy (6 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Physiology (90 citations), Epidemiology (517 citations) and Molecular Biology (935 citations). Carol A. Mercer has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include George Thomas, Alagammai Kaliappan, Sara C. Kozma, Suresh Peddigari, Giulio Donati, Angela F. Drew, Molly M. McFarland-Mancini, Mingfu Zhou, Teng Teng and Hala Elnakat Thomas. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact